Stimulant Use

Uses

Dosage & preparation

Risks & contraindications

Evidence quality

Highlighted claims

• There is no approved pharmacotherapy for stimulant use disorders. — Positive psychological intervention to reduce HIV acquisition risk with men who use stimulants: protocol for a randomised controlled trial
• Stimulant eligibility required moderate or severe stimulant use disorder screening or at least weekly methamphetamine or cocaine use in the past three months. — Positive psychological intervention to reduce HIV acquisition risk with men who use stimulants: protocol for a randomised controlled trial
• Stimulant use, especially methamphetamine use, remains an important driver of HIV incidence among sexual minority men in the United States. — Positive psychological intervention to reduce HIV acquisition risk with men who use stimulants: protocol for a randomised controlled trial
• Behavioral interventions are frontline treatments for stimulant use disorders. — Positive psychological intervention to reduce HIV acquisition risk with men who use stimulants: protocol for a randomised controlled trial
• Stimulant use severity was included as a secondary outcome even though the intervention and remote contingency management were not focused on reducing stimulant use. — Positive psychological intervention to reduce HIV acquisition risk with men who use stimulants: protocol for a randomised controlled trial
• The resurgent methamphetamine epidemic may disproportionately affect Black and Latino sexual minority men. — Positive psychological intervention to reduce HIV acquisition risk with men who use stimulants: protocol for a randomised controlled trial